CRH Medical Corp (CRHM) Rating Reiterated by RBC Capital Markets
CRH Medical Corp (NASDAQ:CRHM)‘s stock had its “outperform” rating reissued by investment analysts at RBC Capital Markets in a research report issued to clients and investors on Saturday. They currently have a $6.50 price objective on the stock. RBC Capital Markets’ price target points to a potential upside of 50.46% from the stock’s current price.
A number of other analysts have also recently issued reports on CRHM. Canaccord Genuity reiterated a “buy” rating on shares of CRH Medical Corp in a research note on Thursday, June 16th. Zacks Investment Research cut shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a research note on Monday, September 5th. Finally, CIBC reiterated an “outperform” rating on shares of CRH Medical Corp in a research note on Tuesday, September 13th.
CRH Medical Corp (NASDAQ:CRHM) opened at 4.32 on Friday. The firm’s 50-day moving average is $3.80 and its 200-day moving average is $3.55. CRH Medical Corp has a 1-year low of $2.15 and a 1-year high of $4.39.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/08/crh-medical-corp-crhm-rating-reiterated-by-rbc-capital-markets.html
Several institutional investors have recently added to or reduced their stakes in the stock. Hillsdale Investment Management Inc. purchased a new position in CRH Medical Corp during the second quarter worth approximately $3,661,000. Stifel Financial Corp purchased a new position in CRH Medical Corp during the second quarter worth approximately $3,051,000. Pacific Ridge Capital Partners LLC purchased a new position in CRH Medical Corp during the second quarter worth approximately $1,985,000. Mackenzie Financial Corp purchased a new position in CRH Medical Corp during the second quarter worth approximately $1,899,000. Finally, Sentry Investments Corp. raised its position in CRH Medical Corp by 1.9% in the second quarter. Sentry Investments Corp. now owns 386,300 shares of the company’s stock worth $1,943,000 after buying an additional 7,300 shares in the last quarter.
About CRH Medical Corp
CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.